Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Decreased corneal thickness, Keratoconus, and Reduced visual acuity.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Decreased corneal thickness, Keratoconus |
TUBA3D function has not been fully characterized.
Keratoconus 9 is associated with mutations in the TUBA3D gene on chromosome 2.
Genetic testing for TUBA3D is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for keratoconus 9 has been reported in the published literature.
Phenotype severity distribution: 3 always present features.
No clinical trials have been registered for keratoconus 9.
201 publications have been identified in PubMed for keratoconus 9. Kisho has analyzed 104 by research type. Research spans Epidemiology / Natural History (24%), Basic Science / Preclinical (19%), and Clinical Trial Publication (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 25 | 24% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
Online Mendelian Inheritance in Man
Laboratory research
20 |
19% |
Clinical study results | 19 | 18% |
Testing and diagnosis research | 18 | 17% |
Research summaries | 12 | 12% |
Patient case studies | 6 | 6% |
New treatment approaches | 4 | 4% |
Chatterjee S (2026). [PMID: 41436661](https://pubmed.ncbi.nlm.nih.gov/41436661/). *Eye (Lond)*. [Clinical Trial Publication]
Petrovic T (2026). [PMID: 42123353](https://pubmed.ncbi.nlm.nih.gov/42123353/). *Int J Mol Sci*. [Epidemiology / Natural History]
Mohammadi F (2026). [PMID: 41016520](https://pubmed.ncbi.nlm.nih.gov/41016520/). *Am J Ophthalmol*. [Review / Meta-Analysis]
Mazzotta C (2026). [PMID: 41485028](https://pubmed.ncbi.nlm.nih.gov/41485028/). *Eye Vis (Lond)*. [Case Report / Case Series]
Alhadlaq S O (2026). [PMID: 42005665](https://pubmed.ncbi.nlm.nih.gov/42005665/). *Health Sci Rep*. [Epidemiology / Natural History]
Rattan SA (2026). [PMID: 42133149](https://pubmed.ncbi.nlm.nih.gov/42133149/). *Int Ophthalmol*. [Basic Science / Preclinical]
Li S (2026). [PMID: 42216341](https://pubmed.ncbi.nlm.nih.gov/42216341/). *Medicine (Baltimore)*. [Basic Science / Preclinical]
Hashemi H (2026). [PMID: 40209114](https://pubmed.ncbi.nlm.nih.gov/40209114/). *Cornea*. [Epidemiology / Natural History]
Zhang J (2026). [PMID: 41966360](https://pubmed.ncbi.nlm.nih.gov/41966360/). *Exp Eye Res*. [Case Report / Case Series]
Maghsoudlou P (2026). [PMID: 30969512](https://pubmed.ncbi.nlm.nih.gov/30969512/). *Unknown Journal*. [Diagnostic / Biomarker]